Union Bancaire Privee, UBP SA
Source: SEC Form 13F · as of Mar 2026Union Bancaire Privee, UBP SA holds 10 biotech & pharma companies tracked by BioSniper, totaling $25.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$25.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Teva Pharmaceutical Industries Limited (TEVA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | 741,433 | $20.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 4,374 | $3.2M |
| GILDGILEAD SCIENCES, INC. | 15,160 | $1.7M |
| SYRESpyre Therapeutics, Inc. | 3,880 | $159K |
| OCULOCULAR THERAPEUTIX, INC | 25,000 | $148K |
| ABVXAbivax SA | 500 | $41K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 200 | $9K |
| MRNAModerna, Inc. | 200 | $9K |
| CARMCarisma Therapeutics Inc. | 785 | $22 |
| TENXTENAX THERAPEUTICS, INC. | 1 | $11 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.